Concepts in disinfection of bacterial populations

Mathematical Biosciences

Volumn 245, Issue 2, 2013, Pages 111-125

  Cogan, N G ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Bacteria; Biofilm; Disinfection; Modeling

Indexed keywords

BACTERIAL POPULATION; HUMAN DISEASE; MULTI-LAYERED; PHENOTYPIC EXPRESSION; TOLERANCE MECHANISMS;

BIOFILMS; DISINFECTION; MATHEMATICAL MODELS; MODELS;

BACTERIA;

BIOFILM; CONCEPTUAL FRAMEWORK; DISINFECTION; EXPERIMENTAL STUDY; MATHEMATICAL ANALYSIS; MICROBIAL ACTIVITY; NUMERICAL MODEL; OPTIMIZATION; PATHOGEN; PHENOTYPE;

BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM; BIOFILM; CONTINUOUS STIRRED TANK REACTOR; DISINFECTION; ENVIRONMENT; GENE MUTATION; GENE STRUCTURE; GENOTYPE; MATHEMATICAL MODEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COMMUNITY; MICROBIAL POPULATION DYNAMICS; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; PLASMID; PSEUDOMONAS AERUGINOSA; REVIEW;

BACTERIA (MICROORGANISMS);

BACTERIA; BIOFILM; DISINFECTION; MODELING;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BIOFILMS; BIOREACTORS; COMPUTATIONAL BIOLOGY; DISINFECTANTS; DISINFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; MODELS, BIOLOGICAL;

EID: 84884151319     PISSN: 00255564     EISSN: 18793134     Source Type: Journal    
DOI: 10.1016/j.mbs.2013.07.007     Document Type: Review

References (111)

1. Fauvart M., De Groote V.N., Michiels J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. Journal of Medical Microbiology 2011, 60(6):699. 10.1099/jmm.0.030932-0.
2. Andersson D.I., Levin B.R. The biological cost of antibiotic resistance. Current Opinion in Microbiology 1999, 2(5):489. http://www.sciencedirect.com/science/article/pii/S1369527499000053. 10.1016/S1369-5274(99)00005-3.
3. Albrich W., Monnet D., Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerging Infectious Diseases 2004, 10(3):514.
4. McGowan J. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Review of Infectious Diseases 1983, 5(6):1033.
5. Fux C., Costerton J., Stewart P., Stoodley P. Survival strategies of infectious biofilms. Trends in Microbiology 2005, 13(1):34.
6. Wolcott R., Ehrlich G. Biofilms and chronic infections. JAMA: The Journal of the American Medical Association 2008, 299(22):2682.
7. Parsek M., Singh P. Bacterial biofilms: an emerging link to disease pathogenesis. Annual Reviews in Microbiology 2003, 57(1):677.
8. Gale E. Mechanisms of antibiotic action. Pharmacological Reviews 1963, 15(3):481.
9. Fischbach M., Walsh C. Antibiotics for emerging pathogens. Science 2009, 325(5944):1089.
10. Dunne W.M. Bacterial adhesion: seen any good biofilms lately?. Clinical Microbiology Reviews 2002, 15(2):155.
11. Uppal A., Ray W., Poore A. On the dynamic behavior of continuous stirred tank reactors. Chemical Engineering Science 1974, 29(4):967.
12. Grady C., Williams D. Effects of influent substrate concentration on the kinetics of natural microbial populations in continuous culture. Water Research 1975, 9(2):171.
13. Niculescu S.-I., Verriest E.I., Dugard L., Dion J.-M. Stability and robust stability of time-delay systems: a guided tour. Stability and Control of Time-Delay Systems 1998, 1. Springer.
14. Lobry J., Flandrois J., Carret G., Pave A. Monod's bacterial growth model revisited. Bulletin of Mathematical Biology 1992, 54(1):117.
15. Neu H.C. The crisis in antibiotic resistance. Science 1992, 257(5073):1064. 10.1126/science.257.5073.1064.
16. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000, 406:775.
17. Murray B.E. Vancomycin-resistant enterococcal infections. The New England Journal of Medicine 2000, 342(10):710.
18. Webber M.A., Piddock L.J.V. The importance of efflux pumps in bacterial antibiotic resistance. Journal of Antimicrobial Chemotherapy 2003, 51(1):9.
19. Schentag J.J., Hyatt J.M., Carr J.R., Paladino J.A., Birmingham M.C., Zimmer G.S., Cumbo T.J. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clinical Infectious Diseases 1998, 26(5):1204. 10.1086/520287.
20. Andersson D.I., Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance?. Nature Reviews Microbiology 2010, 8(4):260.
21. Cogan N.G. Effects of persister formation on bacterial response to dosing. Journal of Theoretical Biology 2006, 238(3):694.
22. Leenheer P.D., Cogan N.G. Failure of antibiotic treatment in microbial populations. Journal of Mathematical Biology 2009, 59(4):563.
23. Imran M., Smith H. A mathematical model of gene transfer in a biofilm. Mathematics for Ecology and Environmental Sciences, Biological and Medical Physics, Biomedical Engineering 2007, 93. Springer, Berlin, Heidelberg. Y. Takeuchi, Y. Iwasa, K. Sato (Eds.).
24. Desai M., Buhler T., Weller P., Brown M. Increasing resistance of planktonic and biofilm cultures of Burkholderia cepecia to ciprofloxacin and ceftazidime during exponential growth. Journal of Antimicrobial Chemotherapy 1998, 42:153.
25. Keren I., Kaldalu N., Spoering A., Wang Y., Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiology Letters 2004, 230:13.
26. Balaban N. Persistence: mechanisms for triggering and enhancing phenotypic variability. Current opinion in Genetics & Development 2011, 21(6):768.
27. Gilbert P., McBain A., Lindsay S. Biofilms, multi-resistance, and persistence. Antimicrobial Resistance in Bacteria 2007, 77. Horizon, Bioscience. C. Amábile-Cuevas (Ed.).
28. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Moscow) 2005, 70(2):267.
29. Magnuson R.D. Hypothetical functions of toxin-antitoxin systems. Journal of Bacteriology 2007, 189(17):6089.
30. Stewart P. Mechanisms of antibiotic resistance in bacterial biofilms. International Journal of Medical Microbiology 2002, 292(2):107.
31. Sanderson S., Stewart P. Evidence of bacterial adaptation to monochloramine in Pseudomonas aeruginosa biofilms and evaluation of biocide action model. Biotechnology and Bioengineering 1997, 56(2):201.
32. Szomolay B., Klapper I., Dockery J., Stewart P. Adaptive responses to antimicrobial agents in biofilms. Environmental Microbiology 2005, 7(8):1186.
33. Lewis K. Riddle of biofilm resistance. Antimicrobial Agents and Chemotherapy 2001, 45(4):999.
34. Balaban N.Q., Merrin J., Chait R., Kowalik L., Leibler S. Bacterial persistence as a phenotypic switch. Science 2005, 305(5690):1622.
35. Kohanski M., Dwyer D., Collins J. How antibiotics kill bacteria: from targets to networks. Nature Reviews Microbiology 2010, 8(6):423.
36. Gefen O., Gabay C., Mumcuoglu M., Engel G., Balaban N.Q. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proceedings of the National Academy of Sciences 2008, 105(16):6145.
37. Fauvart M., De Groote V.N., Michiels J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. Journal of Medical Microbiology 2011, 60(6):699.
38. Scherrer R., Moyed H. Conditional impairment of cell division and altered lethality in hipa mutants of Escherichia coli K-12. Journal of Bacteriology 1988, 170(8):3321.
39. Moyed H., Bertrand K., hipa a newly recognized gene of Escherichia coli k-12 that affects frequency of persistence after inhibition of murein synthesis. Journal of Bacteriology 1983, 155(2):768.
40. Costerton J.W., Lewandowski Z., Caldwell D.E., Korber D.R., Lappin-Scott H.M. Microbial biofilms. Annual Review of Microbiology 1995, 49:711.
41. Branda S.S., Vik Å., Friedman L., Kolter R. Biofilms: the matrix revisited. Trends in Microbiology 2005, 13(1):20.
42. Ryder C., Byrd M., Wozniak D.J. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Current Opinion in Microbiology 2007, 10:644.
43. Hentzer M., Wu H., Andersen J.B., Riedel K., Rasmussen T.B., Bagge N., Kumar N., Schembri M.A., Song Z., Kristoffersen P., Manefield M., Costerton J.W., Molin S., Eberl L., Steinberg P., Kjelleberg S., Hoiby N., Givskov M. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. The EMBO Journal 2003, 22(15):3803.
44. Stoodley P., Sauer K., Davies D.G., Costerton J.W. Biofilms as complex differentiated communities. Annual Review of Microbiology 2002, 56:187.
45. Davies D.G., Parsek M.R., Pearson J.P., Iglewski B.H., Costerton J.W., Greenberg E.P. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998, 280:295.
46. Chopp D.L., Kirisits M.J., Moran B., Parsek M.R. The dependence of quorum sensing on the depth of a growing biofilm. Bulletin of Mathematical Biology 2003, 65(6):1053.
47. Dockery J.D., Keener J.P. A mathematical model for quorum sensing in Pseudomonas aeruginosa. Bulletin of Mathematical Biology 2001, 63(1):95.
48. Chopp D.L., Kirisits M.J., Moran B., Parsek M.R. A mathematical model of quorum sensing in a growing bacterial biofilm. Journal of Industrial Microbiology and Biotechnology 2002, 29(6):339.
49. Anguige K., King J., Ward J. A multi-phase mathematical model of quorum sensing in a maturing Pseudomonas aeruginosa biofilm. Mathematical Biosciences 2006, 203(2):240.
50. Frederick M., Kuttler C., Hense B., Eberl H. A mathematical model of quorum sensing regulated EPS production in biofilm communities. Theoretical Biology and Medical Modelling 2011, 8(8):1.
51. Wanner O., Gujer W. A multispecies biofilm model. Biotechnology and Bioengineering 1986, 28(3):314.
52. Klapper I., Dockery J. Mathematical description of microbial biofilms. SIAM Review 2010, 52(2):221.
53. Dow J.M., Crossman L., Findlay K., He Y.-Q., Feng J.-X., Tang J.-L. Biofilm dispersal in xanthomonas campestris is controlled by cell-cell signaling and is required for full virulence to plants. Proceedings of the National Academy of Sciences 2003, 100(19):10995.
54. Singh P., Cameotra S. Enhancement of metal bioremediation by use of microbial surfactants. Biochemical and Biophysical Research Communications 2004, 319(2):291.
55. Donlan R.M., Donlan R., et al. Biofilms: microbial life on surfaces. Emerging Infectious Diseases 2002, 8(9):881.
56. Davey M.E., O'toole G.A. Microbial biofilms: from ecology to molecular genetics. Microbiology and Molecular Biology Reviews 2000, 64(4):847.
57. Davies D. Understanding biofilm resistance to antibacterial agents. Nature Reviews Drug Discovery 2003, 2(2):114.
58. Rao G. Risk factors for the spread of antibiotic-resistant bacteria. Drugs 1998, 55(3):323.
59. Andersson D. Persistence of antibiotic resistant bacteria. Current Opinion in Microbiology 2003, 6(5):452.
60. Oliver A., Cantón R., Campo P., Baquero F., Blázquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288(5469):1251.
61. Levin B. Models for the spread of resistant pathogens. The Netherlands Journal of Medicine 2002, 60(7 Suppl):58.
62. Levin B., Rozen D. Non-inherited antibiotic resistance. Nature Reviews Microbiology 2006, 4(7):556.
63. Levin B. The evolution and maintenance of virulence in microparasites. Emerging Infectious Diseases 1996, 2(2):93.
64. Imran M., Jones D., Smith H. Biofilms and the plasmid maintenance question. Mathematical Biosciences 2005, 193(2):183.
65. Meyers L., Levin B., Richardson A., Stojiljkovic I. Epidemiology, hypermutation, within-host evolution and the virulence of Neisseria meningitidis. Proceedings of the Royal Society of London, Series B: Biological Sciences 2003, 270(1525):1667.
66. Srensen S.J., Bailey M., Hansen L.H., Kroer N., Wuertz S. Studying plasmid horizontal transfer in situ: a critical review. Nature Reviews Microbiology 2005, 3(9):700.
67. Pilyugin S.S., Waltman P. The simple chemostat with wall growth. SIAM Journal on Applied Mathematics 1999, 59(5):1552.
68. Klapper I., Rupp C., Cargo R., Purvedorj B., Stoodley P. Viscoelastic fluid description of bacterial biofilm material properties. Biotechnology and Bioengineering 2002, 80(3):289.
69. Stoodley P., Lewandowski Z., Boyle J., Lappin-Scott H. Structural deformation of bacterial biofilms caused by short-term fluctuations in fluid shear: an in situ investigation of biofilm rheology. Biotechnology and Bioengineering 2000, 65(1):83.
70. Huang C., Yu F., McFeters G., Stewart P. Nonuniform spatial patterns of respiratory activity within biofilms during disinfection. Applied and Environmental Microbiology 1995, 61(6):2252.
71. Wentland E., Stewart P., Huang C., McFeters G. Spatial variations in growth rate within Klebsiella pneumoniae colonies and biofilm. Biotechnology Progress 2008, 12(3):316.
72. Stewart P., William Costerton J. Antibiotic resistance of bacteria in biofilms. The Lancet 2001, 358(9276):135.
73. Gilbert P., Das J., Foley I. Biofilm susceptibility to antimicrobials. Advances in Dental Research 1997, 11(1):160.
74. Cogan N., Cortez R., Fauci L. Modeling physiological resistance in bacterial biofilms. Bulletin of Mathematical Biology 2005, 67(4):831. 10.1016/j.bulm.2004.11.001.
75. Stewart P.S. Diffusion in biofilms. Journal of Bacteriology 2003, 185(5):1485.
76. Stewart P.S., Costerton J.W. Antibiotic resistance of bacteria in biofilms. The Lancet 2001, 358(9276):135.
77. Stewart P. Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilms. Antimicrobial Agents and Chemotherapy 1994, 38(5):1052.
78. Stewart P., Hamilton M., Goldstein B., Schneider B. Modeling biocide action against biofilms. Biotechnology and Bioengineering 1996, 49(4):445.
79. Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nature Reviews Microbiology 2004, 2:95.
80. Yang L., Haagensen J.A., Jelsbak L., Johansen H.K., Sternberg C., Hiby N., Molin S. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. Journal of Bacteriology 2008, 190(8):2767.
81. Cortez R. The method of regularized stokeslets. SIAM Journal on Scientific Computing 2001, 23(4):1204.
82. Cogan N. Two-fluid model of biofilm disinfection. Bulletin of Mathematical Biology 2008, 70(3):800.
83. Cogan N.G. An extension of the boundary integral method applied to periodic disinfection of a dynamic biofilm. SIAM Journal on Applied Mathematics 2010, 70(7):2281.
84. Zhang T. Modeling of biocide action against biofilm. Bulletin of Mathematical Biology 2012, 74(6):1427.
85. Cogan N., Keener J.P. The role of the biofilm matrix in structural development. Mathematical Medicine and Biology 2004, 21(2):147.
86. Gilbert P., Collier P., Brown M. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrobial Agents and Chemotherapy 1990, 34(9):1623.
87. Stewart P. Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilms. Antimicrobial Agents and Chemotherapy 1994, 38(5):1052.
88. Roberts M.E., Stewart P.S. Modeling antibiotic tolerance in biofilms by accounting for nutrient limitation. Antimicrobial Agents and Chemotherapy 2004, 48(1):48.
89. Eberl H., Sudarsan R. Exposure of biofilms to slow flow fields: The convective contribution to growth and disinfection. Journal of Theoretical Biology 2008, 253(4):788.
90. Khassehkhan H., Hillen T., Eberl H. A nonlinear master equation for a degenerate diffusion model of biofilm growth. Lecture Notes in Computer Science 2009, vol. 5544:735. Springer, Berlin, Heidelberg. G. Allen, J. Nabrzyski, E. Seidel, G.D. van Albada, J. Dongarra, P.M. Sloot (Eds.).
91. Eberl H.J., Efendiev M.A. A transient density dependent diffusion-reaction model for the limitation of antibiotic penetration in biofilms. Electronic Journal of Differential Equations CS10 2003, 123.
92. Proctor R., Von Eiff C., Kahl B., Becker K., McNamara P., Herrmann M., Peters G. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nature Reviews Microbiology 2006, 4(4):295.
93. Proctor R., Kahl B., von Eiff C., Vaudaux P., Lew D., Peters G. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clinical Infectious Diseases 1998, 27(Supplement 1):S68.
94. Singh R., Ray P., Das A., Sharma M. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. Journal of Medical Microbiology 2009, 58(8):1067.
95. Cogan N.G. Incorporating toxin hypothesis into a mathematical model of persister formation and dynamics. Journal of Theoretical Biology 2007, 248(2):340.
96. Cogan N., Brown J., Darres K., Petty K. Optimal control strategies for disinfection of bacterial populations with persister and susceptible dynamics. Antimicrobial Agents and Chemotherapy 2012, 56(9):4816.
97. Cogan N., Szomolay B., Dindos M. Effect of periodic disinfection on persisters in a one-dimensional biofilm model. Bulletin of Mathematical Biology 2013, 75(1):94.
98. Klapper I., Gilbert P., Ayati B., Dockery J., Stewart P. Senescence can explain microbial persistence. Microbiology 2007, 153(11):3623.
99. Mulcahy L., Burns J., Lory S., Lewis K. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. Journal of Bacteriology 2010, 192(23):6191.
100. Johnson P., Levin B. Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLOS Genetics 2013, 9(1):e1003123.
101. Lou C., Li Z., Ouyang Q. A molecular model for persister in E. coli. Journal of Theoretical Biology 2008, 255(2):205.
102. Gjaltema A., Arts P., Van Loosdrecht M., Kuenen J., Heijnen J. Heterogeneity of biofilms in rotating annular reactors: occurrence, structure, and consequences. Biotechnology and Bioengineering 2004, 44(2):194.
103. Characklis W., Marshall K. Biofilms. Wiley Series in Ecological and Applied Microbiology 1990, Wiley, New York.
104. Mudassar I., Smith H. The pharmacodynamics of antibiotic treatment. Computational and Mathematical Methods in Medicine 2006, 7(4):229.
105. Zhang T., Cogan N.G., Wang Q. Phase-field models for biofilms. II. 2-D numerical simulations of biofilm-flow interaction. Communications in Computational Physics 2008, 4(1):72.
106. Zhang T., Klapper I., et al. Mathematical model of biofilm induced calcite precipitation. Water Science and Technology 2010, 61(11):2957.
107. Smith H., Waltman P. The Theory of the Chemostat: Dynamics of Microbial Competition 1995, vol. 13. Cambridge University Press.
108. Sagaut P. Large Eddy Simulation for Incompressible Flows 2000, vol. 3. Springer, Berlin.
109. Launder B., Reece G.J., Rodi W. Progress in the development of a Reynolds-stress turbulence closure. Journal of Fluid Mechanics 1975, 68(03):537.
110. Fogelson A.L., Guy R.D. Immersed-boundary-type models of intravascular platelet aggregation. Computer Methods in Applied Mechanics and Engineering 2008, 197(25):2087.
111. Costerton W., Veeh R., Shirtliff M., Pasmore M., Post C., Ehrlich G., et al. The application of biofilm science to the study and control of chronic bacterial infections. Journal of Clinical Investigation 2003, 112(10):1466.